What does trilink — accumulated goodwill impairment mean?

Represents the total historical impairment charges taken against the goodwill allocated to the TriLink segment. This cumulative figure provides a long-term view of how the segment's valuation has been adjusted downward over time due to changing market conditions. It is an essential metric for assessing the historical success of past acquisitions and the durability of the segment's intangible assets.

Maravai LifeSciences Holdings, Inc. (MRVI) TriLink — Accumulated goodwill impairment

Screener

Other segment segments

Cygnus

$0—

Similar metrics at other companies

OPLNFinance — Accumulated goodwill impairment

$161.5M0.0%

OPLNMarketplace — Accumulated goodwill impairment

$250.8M0.0%

STAutomotive — Accumulated goodwill impairment

$0—

STIndustrials — Accumulated goodwill impairment

$394.3M+134%

IRMCORPORATE AND OTHER — Accumulated goodwill impairment

$26.01M0.0%

IRMGLOBAL RIM BUSINESS — Accumulated goodwill impairment

$132.41M0.0%

Other financials

Income statement

See full

Revenue$51.4M+8.5%

Gross profit$20.7M+166%

Operating income-$15.1M+77.2%

Net income-$12.4M+68.6%

EPS (diluted)-$0.08+70.4%

Balance sheet

See full

Cash & equivalents$70.6M-73.8%

Total debt$176.7M-52.4%

Total equity$204.6M-23.0%

Total assets$603.7M-32.7%

Cash flow

See full

Operating cash flow$4.0M+139%

CapEx$370.0K-87.1%

Free cash flow$3.6M+128%

Valuation

See full

Market cap$918.96M+210%

Enterprise value$1.03B+158%

P/S4.4×+3.1×

Profitability

See full

Gross margin34.9%+4.4pp

Operating margin-56.1%-21.3pp

Net margin-37.1%-13.6pp

FCF margin-17.2%—

Returns & leverage

See full

Return on equity-32.9%-9.4pp

Debt / equity0.9×-0.5×

Current ratio4.1×-1.1×

Where this comes from

Reported directly by Maravai LifeSciences Holdings, Inc. in its filing.

Tagged under the XBRL concept us-gaap:GoodwillImpairedAccumulatedImpairmentLoss.

The source filing: Maravai LifeSciences Holdings, Inc.’s 10-K, filed February 26, 2026.

Filed: Feb 26, 2026, 4:06 PM EST
Fiscal year: FY2025
Accession: 0001823239-26-000011

(1) The TriLink segment had accumulated goodwill impairment of $209.0 million and $166.2 million as of December 31, 2025 and 2024, respectively. The TriLink segment includes the TriLink BioTechnologies, Glen Research, and Alphazyme reporting units.

Item 8. Financial Statements and Supplementary Data

FAQ

What is Maravai LifeSciences Holdings, Inc.'s trilink — accumulated goodwill impairment?: Maravai LifeSciences Holdings, Inc. (MRVI) reported trilink — accumulated goodwill impairment of $209M in Q4 2025.
What does trilink — accumulated goodwill impairment mean?: Represents the total historical impairment charges taken against the goodwill allocated to the TriLink segment. This cumulative figure provides a long-term view of how the segment's valuation has been adjusted downward over time due to changing market conditions. It is an essential metric for assessing the historical success of past acquisitions and the durability of the segment's intangible assets.